Delivery Order SPE2DR25D3201-SPE2DR26FT5CD
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $41,589.18 to AmerisourceBergen Drug Corp on June 5, 2025, with an ultimate completion date of June 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,003.28 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,976.57 to AmerisourceBergen Drug Corp on December 9, 2025, with completion targeted for December 10, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The delivery order represents one of numerous...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,594.24 to AmerisourceBergen Drug Corp on August 19, 2025, with completion anticipated by August 20, 2025. This firm fixed-price delivery order, issued under a competitive procurement with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $12,821.24 to AmerisourceBergen Drug Corp on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,463.76 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $39,523.47 to AmerisourceBergen Drug Corp on June 13, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a $191,027.20 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the contractor's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,832.58 to AmerisourceBergen Drug Corp on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $7,240 delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract, designated as a non-competitive award with no set-aside provisions, represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5CDDelivery Order
The Defense Logistics Agency awarded a $7,299.02 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Tevimbra 100 mg/10 mL vials. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Logistics Agency's Medical Supply Chain across a comprehensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. As a primary pharmaceutical supplier under the DLA's global pharmaceutical support vehicle, the company fulfills orders spanning specialty medications, brand-name and generic drugs, vaccines, and other medical commodities for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects the company's ongoing role as a key pharmaceutical distributor within the federal procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 1/4/26 |